Based on these properties, recombinant GDF15 and GDF15 analogs have been explored as potential therapeutic agents for obesity, demonstrating robust weight loss effects in preclinical and early-phase clinical studies [38,39]. The gene discussed is GDF15; the disease is obesity disorder.